Structural Basis for the Inhibition of Histone Deacetylase 8 (HDAC8), a Key Epigenetic Player in the Blood Fluke Schistosoma mansoni
Open accessThe DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
Abstract
The treatment of schistosomiasis, a disease caused by blood flukes parasites of the Schistosoma genus, depends on the intensive use of a single drug, praziquantel, which increases the likelihood of the development of drug-resistant parasite strains and renders the search for new drugs a strategic priority. Currently, inhibitors of human epigenetic enzymes are actively investigated as novel anti-cancer drugs and have the potential to be used as new anti-parasitic agents. Here, we report that Schistosoma mansoni histone deacetylase 8 (smHDAC8), the most expressed class I HDAC isotype in this organism, is a functional acetyl-L-lysine deacetylase that plays an important role in parasite infectivity. The crystal structure of smHDAC8 shows that this enzyme adopts a canonical α/β HDAC fold, with specific solvent exposed loops corresponding to insertions in the schistosome HDAC8 sequence. Importantly, structures of smHDAC8 in complex with generic HDAC inhibitors revealed specific structural changes in the smHDAC8 active site that cannot be accommodated by human HDACs. Using a structure-based approach, we identified several small-molecule inhibitors that build on these specificities. These molecules exhibit an inhibitory effect on smHDAC8 but show reduced affinity for human HDACs. Crucially, we show that a newly identified smHDAC8 inhibitor has the capacity to induce apoptosis and mortality in schistosomes. Taken together, our biological and structural findings define the framework for the rational design of small-molecule inhibitors specifically interfering with schistosome epigenetic mechanisms, and further support an anti-parasitic epigenome targeting strategy to treat neglected diseases caused by eukaryotic pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“We have previously shown that our smHDAC8 crystals can be used to look at inhibitor binding in a crystal latticeunbiased manner 29, 30, 55-58 .”
From Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants (2018) · cites this paper as [30]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“we previously observed a very similar binding mode to smHDAC8 for another pan-HDAC inhibitor, M344, including an interaction between D100 and the M344 internal amide group 30”
From Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants (2018) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · cited 1×
“Each experiment was repeated 3–5 times and analyzed using the DDCt method [53].”
Method[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716 · cited 3×
“8 Å resolution was solved by molecular replacement with Phenix [57] using the hHDAC8 structure (PDB 1T69) as a search model.”
MethodInfluentialJalview Version 2—a multiple sequence alignment editor and analysis workbench
Waterhouse, A. M., Procter, J. B., Martin, D. M. A., Clamp, M., & Barton, G. J. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp033 · Cited by 10,235
LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions
Wallace, A. C., Laskowski, R. A., & Thornton, J. M. (1995) · "Protein Engineering, Design and Selection" · doi:10.1093/protein/8.2.127 · Cited by 5,690 · cited 1×
“Alignments were generated with JalView [61], structural panels in figures were generated with PyMOL (DeLano Scientific), and schematic interactions of the inhibitors with smHDAC8 were generated with LigPlot [62]).”
MethodJones, P. A., & Baylin, S. B. (2007) · Cell · doi:10.1016/j.cell.2007.01.029 · Cited by 4,515
Cancer epigenetics: from mechanism to therapy
Dawson, M. A., & Kouzarides, T. (2012) · Cell · doi:10.1016/j.cell.2012.06.013 · Cited by 3,203
A decade of exploring the cancer epigenome—biological and translational implications
Baylin, S. B., & Jones, P. A. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3130 · Cited by 2,871
The challenge of emerging and re-emerging infectious diseases
Morens, D. M., Folkers, G. K., & Fauci, A. S. (2004) · Nature · doi:10.1038/nature02759 · Cited by 2,103
Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors
Finnin, M. S., Donigian, J. R., Cohen, A., Richon, V. M., Rifkind, R. A., Marks, P. A., Breslow, R., & Pavletich, N. P. (1999) · Nature · doi:10.1038/43710 · Cited by 1,714
Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation
Jones, G., Willett, P., & Glen, R. C. (1995) · Journal of Molecular Biology · doi:10.1016/s0022-2836(95)80037-9 · Cited by 1,546
Histone deacetylase inhibitors: molecular mechanisms of action
Xu, W. S., Parmigiani, R. B., & Marks, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210620 · Cited by 1,542
Epigenetic protein families: a new frontier for drug discovery
Arrowsmith, C. H., Bountra, C., Fish, P. V., Lee, K., & Schapira, M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3674 · Cited by 1,327 · cited 1×
“Most HDAC inhibitors that are currently approved for use in humans, or are in clinical trials are, at best, moderately selective for an HDAC class [48] and not for one particular enzyme.”
BackgroundA class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases
Richon, V. M., Emiliani, S., Verdin, E., Webb, Y., Breslow, R., Rifkind, R. A., & Marks, P. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3003 · Cited by 914 · cited 1×
“Towards this goal, we first determined the structures of smHDAC8 in complex with two generic HDAC inhibitors, SAHA (N-hydroxy-N9-phenyloctanediamide; [44]) and M344 (N-hydroxy-7-(4-dimethylaminobenzoyl)-aminoheptanamide; [45]), either by co-crystallization or by soaking.”
MethodHistone Deacetylase Inhibitors in Cancer Therapy
Lane, A. A., & Chabner, B. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.1291 · Cited by 874
Ross, A. G. P., Bartley, P. B., Sleigh, A. C., Olds, G. R., Li, Y., Williams, G. M., & McManus, D. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra012396 · Cited by 870
Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis
Doenhoff, M. J., Cioli, D., & Utzinger, J. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328318978f · Cited by 806
Epigenetic modifications as therapeutic targets
Kelly, T. K., De Carvalho, D. D., & Jones, P. A. (2010) · Nature Biotechnology · doi:10.1038/nbt.1678 · Cited by 793
The genomes of four tapeworm species reveal adaptations to parasitism
The Taenia solium Genome Consortium, Tsai, I. J., Zarowiecki, M., Holroyd, N., Garciarrubio, A., Sanchez-Flores, A., Brooks, K. L., Tracey, A., Bobes, R. J., Fragoso, G., et al. (2013) · Nature · doi:10.1038/nature12031 · Cited by 760 · cited 1×
“Strikingly, smHDAC8 S18 but also smHDAC8 H292 are conserved in the recently published HDAC8 sequences of the cestodes Echinococcus multilocularis, Echinococcus granulosus and Taenia solium [51] that also cause serious human diseases (Figure S7).”
BackgroundChemical phylogenetics of histone deacetylases
Bradner, J. E., West, N., Grachan, M. L., Greenberg, E. F., Haggarty, S. J., Warnow, T., & Mazitschek, R. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.313 · Cited by 720
Refinement of severely incomplete structures with maximum likelihood in BUSTER–TNT
Blanc, E., Roversi, P., Vonrhein, C., Flensburg, C., Lea, S. M., & Bricogne, G. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904016427 · Cited by 717 · cited 1×
“The initial models were refined through several cycles of manual building using COOT [58,59] and automated refinement with Phenix [57] and Buster [60].”
MethodStructural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases
Somoza, J. R., Skene, R. J., Katz, B. A., Mol, C., Ho, J. D., Jennings, A. J., Luong, C., Arvai, A., Buggy, J. J., Chi, E., et al. (2004) · Structure · doi:10.1016/j.str.2004.04.012 · Cited by 710
Vannini, A., Volpari, C., Filocamo, G., Casavola, E. C., Brunetti, M., Renzoni, D., Chakravarty, P., Paolini, C., De Francesco, R., Gallinari, P., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404603101 · Cited by 638 · cited 4×
“It has been suggested that human HDAC8 [39] contains an exit channel for the cleaved acetate molecule that starts at the bottom of the catalytic cavity and goes through the enzyme, a feature also observed in bacterial histone deacetylase-like proteins (HDLPs)”
BackgroundInfluentialParasites and poverty: The case of schistosomiasis
King, C. H. (2010) · Acta Tropica · doi:10.1016/j.actatropica.2009.11.012 · Cited by 579
HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle
Deardorff, M. A., Bando, M., Nakato, R., Watrin, E., Itoh, T., Minamino, M., Saitoh, K., Komata, M., Katou, Y., Clark, D., et al. (2012) · Nature · doi:10.1038/nature11316 · Cited by 577
Innovative lead discovery strategies for tropical diseases
Nwaka, S., & Hudson, A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2144 · Cited by 521 · cited 1×
“To speed up the search for novel anti-parasitic drugs, a ‘‘piggyback’’ strategy can be used that builds on chemical scaffolds previously validated for other diseases [24].”
BackgroundStructure of Hdac3 Bound to Co-Repressor and Inositol Tetraphosphate
Watson, P. J., Fairall, L., Santos, G. M., & Schwabe, J. W. R. (2012) · Nature · doi:10.1038/nature10728 · Cited by 505
Ismail, M., Botros, S., Metwally, A., William, S., Farghally, A., Tao, L. F., Day, T. A., & Bennett, J. L. (1999) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.1999.60.932 · Cited by 495
Balasubramanian, S., Ramos, J., Luo, W., Sirisawad, M., Verner, E., & Buggy, J. J. (2008) · Leukemia · doi:10.1038/leu.2008.9 · Cited by 458
Diagnosis and management of schistosomiasis
Gray, D. J., Ross, A. G., Li, Y.-S., & McManus, D. P. (2011) · BMJ · doi:10.1136/bmj.d2651 · Cited by 427 · cited 1×
“deaths yearly, with about 800 million people further at risk of infection [8].”
BackgroundRamalho-Pinto, F. J., Gazzinelli, G., Howells, R. E., Mota-Santos, T. A., Figueiredo, E. A., & Pellegrino, J. (1974) · Experimental Parasitology · doi:10.1016/0014-4894(74)90076-9 · Cited by 368 · cited 2×
“Schistosomula were obtained by mechanical transformation of cercariae [52] of the LE strain of S.”
MethodStructure, mechanism, and inhibition of histone deacetylases and related metalloenzymes
Lombardi, P. M., Cole, K. E., Dowling, D. P., & Christianson, D. W. (2011) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2011.08.004 · Cited by 277 · cited 1×
“In humans, histone deacetylases (HDACs) are among the most studied epigenetic targets [25], and a variety of HDAC inhibitors affecting cancer cells have been discovered [26–29].”
BackgroundExploration of the HDAC2 foot pocket: Synthesis and SAR of substituted N-(2-aminophenyl)benzamides
Bressi, J. C., Jennings, A. J., Skene, R., Wu, Y., Melkus, R., Jong, R. D., O’Connell, S., Grimshaw, C. E., Navre, M., & Gangloff, A. R. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.03.091 · Cited by 261
Schuetz, A., Min, J., Allali-Hassani, A., Schapira, M., Shuen, M., Loppnau, P., Mazitschek, R., Kwiatkowski, N. P., Lewis, T. A., Maglathin, R. L., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707362200 · Cited by 257
Vannini, A., Volpari, C., Gallinari, P., Jones, P., Mattu, M., Carfí, A., De Francesco, R., Steinkühler, C., & Di Marco, S. (2007) · The EMBO Reports · doi:10.1038/sj.embor.7401047 · Cited by 256
Resistance of Schistosoma mansoni to praziquantel: is there a problem?
Doenhoff, M. J., Kusel, J. R., Coles, G. C., & Cioli, D. (2002) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(02)90405-0 · Cited by 252
Wovkulich, P. M., Shankaran, K., Kiegiel, J., & Uskokovic, M. R. (1993) · The Journal of Organic Chemistry · doi:10.1021/jo00056a013 · Cited by 192
Jung, M., Brosch, G., Kölle, D., Scherf, H., Gerhäuser, C., & Loidl, P. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm991091h · Cited by 176 · cited 1×
“Towards this goal, we first determined the structures of smHDAC8 in complex with two generic HDAC inhibitors, SAHA (N-hydroxy-N9-phenyloctanediamide; [44]) and M344 (N-hydroxy-7-(4-dimethylaminobenzoyl)-aminoheptanamide; [45]), either by co-crystallization or by soaking.”
MethodSelf-citationCancer Chemoprevention by Targeting the Epigenome
Huang, J., Plass, C., & Gerhauser, C. (2011) · Current Drug Targets · doi:10.2174/138945011798184155 · Cited by 169
HDAC inhibitors in parasitic diseases
Andrews, K. T., Haque, A., & Jones, M. K. (2012) · Immunology & Cell Biology · doi:10.1038/icb.2011.97 · Cited by 161 · cited 2×
“To tackle this bottleneck, the use of structural data, obtained either from modeling or crystallographic/NMR studies, appears decisive [2].”
BackgroundMethodCrystal Structure of a Bacterial Class 2 Histone Deacetylase Homologue
Nielsen, T. K., Hildmann, C., Dickmanns, A., Schwienhorst, A., & Ficner, R. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.065 · Cited by 158
Diebold, M.-L., Fribourg, S., Koch, M., Metzger, T., & Romier, C. (2011) · Journal of Structural Biology · doi:10.1016/j.jsb.2011.02.001 · Cited by 154 · cited 2×
“The amplified gene was cloned between the NdeI and BamHI sites of the pnEA/tH vector encoding a Cterminal thrombin cleavage site followed by a His-tag [55].”
MethodSelf-citationVennervald, B. J., & Polman, K. (2009) · Parasite Immunology · doi:10.1111/j.1365-3024.2009.01163.x · Cited by 149 · cited 1×
“sinensis are also linked with the progression of cancer (reviewed in [50]).”
Background“Manifesto” for Advancing the Control and Elimination of Neglected Tropical Diseases
Hotez, P. J., & Pecoul, B. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000718 · Cited by 138 · cited 1×
“The need for new drugs against eukaryotic parasites is acute, notably for the neglected parasitic diseases [1] for which no effective vaccines have yet been developed and for which the limited number of drugs available for treatment makes increasingly likely the selection of resistant parasite strains [2–5].”
BackgroundDubois, F., Caby, S., Oger, F., Cosseau, C., Capron, M., Grunau, C., Dissous, C., & Pierce, R. J. (2009) · Molecular and Biochemical Parasitology · doi:10.1016/j.molbiopara.2009.06.001 · Cited by 129
Self-citationPotent Antimalarial Activity of Histone Deacetylase Inhibitor Analogues
Andrews, K. T., Tran, T. N., Lucke, A. J., Kahnberg, P., Le, G. T., Boyle, G. M., Gardiner, D. L., Skinner-Adams, T. S., & Fairlie, D. P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00757-07 · Cited by 115
Patel, V., Mazitschek, R., Coleman, B. I., Nguyen, C., Urgaonkar, S., Cortese, J. F., Barker, R. H., Greenberg, E. F., Tang, W., Bradner, J. E., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801654y · Cited by 96
Haigentz, M., Kim, M., Sarta, C., Lin, J., Keresztes, R. S., Culliney, B. E., Gaba, A. G., Smith, R. V., Shapiro, G. I., Chirieac, L. R., et al. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.05.024 · Cited by 90
Watanabe, Y., Iida, H., & Kibayashi, C. (1989) · The Journal of Organic Chemistry · doi:10.1021/jo00278a020 · Cited by 84
Norton, A., Gower, C., Lamberton, P. H. L., Webster, B. L., Lwambo, N. J. S., Blair, L., Fenwick, A., & Webster, J. P. (2010) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2010.10-0283 · Cited by 80
Targeting the epigenome for treatment of cancer
Geutjes, E.-J., Bajpe, P. K., & Bernards, R. (2011) · Oncogene · doi:10.1038/onc.2011.552 · Cited by 71
Oxidations by thionyl chloride. VI. Mechanism of the reaction with cinnamic acids
Higa, T., & Krubsack, A. J. (1975) · The Journal of Organic Chemistry · doi:10.1021/jo00909a007 · Cited by 71
The class I histone deacetylases of the platyhelminth parasite Schistosoma mansoni
Oger, F., Dubois, F., Caby, S., Noël, C., Cornette, J., Bertin, B., Capron, M., & Pierce, R. J. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.10.090 · Cited by 70 · cited 2×
“The full-length cDNA for smHDAC8 [34] was PCR-amplified using the forward primer smHDAC8-N (59-GGATATCCATATGTCTGTTGGGATCGTTTATG-39) and the reverse primer smHDC8-CNS (59-CGCGGATCCCATACCAGTTAAATTATATAATTG-39).”
BackgroundMethodSelf-citationPraziquantel and Schistosomiasis
Dömling, A. S. S., & Khoury, K. (2010) · ChemMedChem · doi:10.1002/cmdc.201000202 · Cited by 70 · cited 1×
“The dependence of the control of schistosomiasis on mass treatment with a single drug, praziquantel [9], and the consequent risk of the appearance of resistant strains raises the spectre of widespread drug resistance [10–13].”
BackgroundTargeting Schistosome Histone Modifying Enzymes for Drug Development
Pierce, R. J. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212801327248 · Cited by 70 · cited 2×
“Interestingly, many human parasites share several characteristics with malignant tumors, including high metabolic activity, a dependence on lactate fermentation as an energy source within the human host, uncontrolled (by the host) cell division, and a degree of invisibility to the host immune responses [23].”
BackgroundSelf-citationMukherjee, P. K., Pradhan, A., Shah, F., Tekwani, B. L., & Avery, M. A. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.03.005 · Cited by 68
[A perfusion technic for recovery of Schistosoma mansoni from experimentally infected guinea pigs].
Pellegrino, J., & SIQUEIRA, A. F. (1956) · PubMed · Cited by 68
HDAC Inhibitors and Cancer Therapy
Atadja, P. W. (2010) · Springer eBooks · doi:10.1007/978-3-7643-8989-5_9 · Cited by 62
Pyridylalanine‐Containing Hydroxamic Acids as Selective HDAC6 Inhibitors
Schäfer, S., Saunders, L. R., Schlimme, S., Valkov, V., Wagner, J. M., Kratz, F., Sippl, W., Verdin, E. M., & Jung, M. (2008) · ChemMedChem · doi:10.1002/cmdc.200800196 · Cited by 42 · cited 1×
“ChemScore was used as scoring function due to the success of ChemScore in earlier HDAC dockings [64].”
MethodSelf-citationAntimalarial histone deacetylase inhibitors containing cinnamate or NSAID components
Wheatley, N. C., Andrews, K. T., Tran, T. L., Lucke, A. J., Reid, R. C., & Fairlie, D. P. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.09.096 · Cited by 38
Chromatin regulation in schistosomes and histone modifying enzymes as drug targets
Pierce, R. J., Dubois, F., Caby, S., Trolet, J., Lancelot, J., Oger, F., Bertheaume, N., & Roger, E. (2011) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762011000700003 · Cited by 37
Self-citationStolfa, D. A., Stefanachi, A., Gajer, J. M., Nebbioso, A., Altucci, L., Cellamare, S., Jung, M., & Carotti, A. (2012) · ChemMedChem · doi:10.1002/cmdc.201200193 · Cited by 20 · cited 1×
“Inhibition data for human HDACs 1, 3 and 6 were obtained according to published procedures with Z(Ac)Lys-AMC as the substrate and trypsin as the developing agent [67].”
MethodSelf-citationDecitabine for acute myeloid leukemia
Marks, P. W. (2012) · Expert Review of Anticancer Therapy · doi:10.1586/era.11.207 · Cited by 14
Romidepsin: A Guide to its Clinical Use in Cutaneous T-Cell Lymphoma
Lyseng-Williamson, K. A., & Yang, L. P. H. (2011) · American Journal of Clinical Dermatology · doi:10.2165/11208520-000000000-00000 · Cited by 10
Conlon, C., & Brown, M. (2011) · Clinical Medicine · doi:10.7861/clinmedicine.11-5-479 · Cited by 5
Research works printed but not linked: 1
- KJ Prasad, 2010, Emerging and re-emerging parasitic diseases, J Int Med Sci Acad, 23, 45
Cited by
Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
Mottamal, M., Zheng, S., Huang, T., & Wang, G. (2015) · Molecules · doi:10.3390/molecules20033898 · Cited by 680
“For example, a potential inhibitor of Schistosoma mansoni HDAC8 (smHDAC8) for the treatment of schistosomiasis, a parasitic disease caused by blood flukes of the genus Schistosoma, was identified by screening the Enamine purchasable compound library [193].”
BackgroundInside HDACs with more selective HDAC inhibitors
Roche, J., & Bertrand, P. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.05.047 · Cited by 312
HDAC8: a multifaceted target for therapeutic interventions
Chakrabarti, A., Oehme, I., Witt, O., Oliveira, G., Sippl, W., Romier, C., Pierce, R. J., & Jung, M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.013 · Cited by 284
Self-citationTargeting Class I Histone Deacetylases in a “Complex” Environment
Millard, C. J., Watson, P. J., Fairall, L., & Schwabe, J. W. R. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.12.006 · Cited by 180
“Interestingly, structural differences between HDAC8 in humans and the blood fluke Schistosoma mansoni suggest that it may be possible to use HDAC inhibitors as antiparasitic agents [89].”
BackgroundInnovation in neglected tropical disease drug discovery and development
Weng, H.-B., Chen, H.-X., & Wang, M.-W. (2018) · Infectious Diseases of Poverty · doi:10.1186/s40249-018-0444-1 · Cited by 161
Metadata
- Authors
- Marek, M., Kannan, S., Hauser, A.-T., Moraes Mourão, M., Caby, S., Cura, V., Stolfa, D. A., Schmidtkunz, K., Lancelot, J., Andrade, L., Renaud, J.-P., Oliveira, G., Sippl, W., Jung, M., Cavarelli, J., Pierce, R. J., & Romier, C.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Martin Luther University Halle-Wittenberg (DE)
- University of Freiburg (DE)
- Fiocruz Minas (BR)
- Corresponding author
- Pierce, Raymond J.
- Romier, Christophe
- ORCID
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-09-26
- Volume
- 9
- Issue
- 9
- Pages
- e1003645
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC3784479
- OpenAlex
- W1964248507
- Cited by
- 173
- References
- 68
- Citations by year
- 2026: 1 · 2025: 9 · 2024: 13 · 2023: 7 · 2022: 15 · 2021: 11 · 2020: 20 · 2019: 18 · 2018: 15 · 2017: 17 · 2016: 18 · 2015: 16 · 2014: 13
- FWCI
- 7.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Americanae (AECID Library) (publishedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- Arca - Repositório Institucional da Fiocruz (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- LillOA (Université de Lille (University Of Lille)) (submittedVersion, other-oa)
- univOAK (4 institutions : Université de Strasbourg, Université de Haute Alsace, INSA Strasbourg, Bibliothèque Nationale et Universitaire de Strasbourg) (submittedVersion, cc-by)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Funders
- European Commission (241865)
- Agence Nationale de la Recherche (ANR-10-INBS-0005)
- European Synchrotron Radiation Facility
- Institut National de la Santé et de la Recherche Médicale
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (2009-3, 573839/2008-5)
- Centre National de la Recherche Scientifique
- Fundação de Amparo à Pesquisa do Estado de Minas Gerais (PPM-00439-10)
- French Infrastructure for Integrated Structural Biology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- Schistosoma mansoni, HDAC8, HDAC8 inhibitors, epigenetic drug targets, schistosomiasis, praziquantel resistance, crystal structure, structure-based inhibitor design, small molecule inhibitors, parasite infectivity, apoptosis, neglected tropical diseases
- MeSH terms
- Animals, Histone Deacetylases, Humans, Schistosoma mansoni, Helminth Proteins, Protein Structure, Secondary, Protein Folding, Epigenesis, Genetic, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.